National Center for Complementary and Alternative Medicine; Notice of Closed Meeting, 10230 [07-1039]
Download as PDF
10230
Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiancy Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1041 Filed 3–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
sroberts on PROD1PC70 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language itnerpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: March 29–30, 2007.
Time: March 29, 2007, 8:45 a.m. to 5:30
p.m.
Agenda: 1. Approval of Minutes; 2. Report
from Dr. John E. Niederhuber, NCI Director;
3. Reports on NCI Budget; Legislative
Activity; NCI Scientific Initiatives by NCI
Staff; Reports of DCLG Working Group and
member activity; 4. Report on NCI Listens
and Learns Evaluations; 5. Public Comment.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conf. Rm. 6,
Bethesda, MD 20892.
Time: March 30, 2007, 2:00 p.m. to 3:30
p.m.
Agenda: Action Items and Conclusion.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conf. Rm 6,
Bethesda, MD 20892.
Contact Person: Barbara Guest, Executive
Secretary, Office of Liaison Activities,
National Cancer Institute, National Institutes
of Health, 6116 Executive Blvd., Room 2202,
Bethesda, MD 20892–8324, 301–496–0307,
guestb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has institute
stringent procedures for entrance onto the
VerDate Aug<31>2005
18:25 Mar 06, 2007
Jkt 211001
NIH campus. All visitor vehicles, including
taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus.
Visitors will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1035 Filed 3–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 15, 2007, 12 p.m. to February
15, 2007, 6 p.m., National Institutes of
Health, 6116 Executive Boulevard,
Bethesda, MD 20892 which was
published in the Federal Register on
January 30, 2007, 72FR4276.
The meeting notice is changed to
reflect the date change from February
15, 2007 to March 7, 2007. The meeting
is closed to the public.
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Mechanisms of
Immune Modulation.
Date: March 22–23, 2007.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hills
Road, Bethesda, MD 20814.
Contact Person: Martina Schmidt, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–594–3456,
schmidma@mail.nih.gov.
Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1039 Filed 3–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEATLH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Closed
Meeting
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, Loan Repayment
Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1036 Filed 3–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
E:\FR\FM\07MRN1.SGM
07MRN1
Agencies
[Federal Register Volume 72, Number 44 (Wednesday, March 7, 2007)]
[Notices]
[Page 10230]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1039]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Alternative Medicine Special Emphasis Panel, Mechanisms of Immune
Modulation.
Date: March 22-23, 2007.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hills Road, Bethesda, MD
20814.
Contact Person: Martina Schmidt, PhD, Scientific Review
Administrator, Office of Scientific Review, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd.,
Suite 401, Bethesda, MD 20892, 301-594-3456, schmidma@mail.nih.gov.
Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1039 Filed 3-6-07; 8:45 am]
BILLING CODE 4140-01-M